Clinical Trial Update: A Study of NIDO-361 in Patients With SBMA [Phase 2]

View source ↗

Summary

Phase 2 study of NIDO-361 in Spinal and Bulbar Muscular Atrophy (Kennedy’s Disease) has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal and Bulbar Muscular Atrophy

Drugs mentioned

• NIDO-361

Snippet

Sponsor: Nido Biosciences, Inc. | Conditions: Spinal and Bulbar Muscular Atrophy, Kennedy's Disease | Phase 2 | Status: COMPLETED | Results posted: 2026-03-03